Work

Bortezomib mitigates adverse prognosis conferred by Bcl-2 overexpression in patients with relapsed/refractory multiple myeloma

Year: 2011

Type: article

Source: Leukemia & lymphoma/Leukemia and lymphoma

DOI: 10.3109/10428194.2011.637212

Authors: Sikander Ailawadhi, Jeff Miecznikowski, Dan P. Gaile, Dongliang Wang, Taimur Sher, George Mulligan, Barb Bryant, Gregory E. Wilding, Terry Mashtare, Leighton Stein, Aisha Masood, Rachel Neuwirth, Kelvin P. Lee, Asher Chanan-Khan

Institutions: University of Southern California, Roswell Park Comprehensive Cancer Center, SUNY Upstate Medical University, Takeda Oncology (United States)

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2147542174

FWCI: 1.317

Cites: 50

Cited by: 20

Related to: 10